09:32 恒生科技指数跌超1% PEEK材料、军工、液冷服务器、稀土永磁、创新药题材跌幅靠前；脑机接口概念股走强。 （更新中） 09:52 N天富龙上市首日高开200.81%，现涨逾191%。 | | | 分时 多日 1分 5分 15分 30分 60分 日 周 月 更多 | | | | | F9 | | --- | --- | --- | --- | --- | --- | --- | --- | | 82.00 | | | | 603406[N天富龙] 09:50 价 68.87 涨跌 45.27(191.82%) 均价 72.06 成交量 337 成交金额 243万 | | | | | 72.27 V | M | | | | | | | | 62.53 | | | | | | | | | 52.80 | | | | | | | | | 43.07 | | | | | | | | | 33.33 | | | | | | | | | 23.60 | | | | | | | | | 13.87 | | | | | | | | | 4.13 | | | | | | | | | -5.60 | | | | | | ...

Group 1 - The brain-computer interface sector opened high, with Innovation Medical (002173) hitting the limit-up price at the opening [1] - Sanbo Brain Science (301293), Jihua Group (601718), Zhongke Information (300678), and Xiangyu Medical also experienced upward movement [1]

Market Overview - A-share indices showed mixed performance on August 7, 2025, with the Shanghai Composite Index slightly up by 0.16% closing at 3639.67 points, while the Shenzhen Component and ChiNext fell by 0.18% and 0.68% respectively [1] - Total trading volume across Shanghai, Shenzhen, and Beijing reached 1852.74 billion yuan, with 3116 stocks declining and 2150 stocks rising [1] Electronic Sector - The electronic sector was a market highlight with 13 stocks hitting the daily limit up, including Tianyu Digital Science and Technology, which closed at 7.45 yuan with a limit-up order volume of 295 million yuan [2] - The wireless earphone concept saw an overall increase of 1.08%, with stocks like Ningbo Yunsheng and Huasheng Tiancai receiving over 500 million yuan in net inflows, indicating growing investor interest in the consumer electronics supply chain [2] Rare Earth Permanent Magnet Sector - The rare earth permanent magnet sector continued its recent upward trend, with stocks like Ningbo Yunsheng and Zhenghai Magnetic Materials hitting the daily limit up [3] - Ningbo Yunsheng attracted a net inflow of 565 million yuan, closing at 13.17 yuan with a turnover rate of 15.48%, driven by increasing demand for rare earth materials in the electric vehicle and wind power sectors [3] Medical Sector - The medical and biological sector exhibited a structural market, with stocks like Innovation Medical and Shangrong Medical hitting the daily limit up [4] - Innovation Medical closed at 17.47 yuan with a turnover rate of 30.10% and a limit-up order volume exceeding 130 million yuan, while other segments like CXO and innovative drugs showed weak performance, highlighting significant capital divergence within the sector [4] Fund Flows - The semiconductor sector saw a net inflow of 4.467 billion yuan, followed by medical devices and energy metals [5] - Conversely, the automotive parts sector experienced a net outflow of 4.185 billion yuan, with noticeable withdrawals in specialized equipment and chemical pharmaceuticals [5] - Stocks like Great Wall Military Industry, Huasheng Tiancai, and Jihua Group were among those with significant limit-up order volumes, reflecting short-term capital preferences for military and computing sectors [5]

Core Insights - The latest net value of Zhongyin Innovation Medical Mixed A (007718) is 2.1723 yuan, reflecting a decline of 3.54%. The fund has shown a one-month return of 12.66%, a six-month return of 78.76%, and a year-to-date return of 80.53% [1]. Fund Performance - The fund ranks 684 out of 4457 in the one-month category, 23 out of 4316 in the six-month category, and 29 out of 4287 in the year-to-date category [1]. Holdings Overview - The top ten stock holdings of Zhongyin Innovation Medical Mixed A account for a total of 62.83%, with significant positions in companies such as: - Innovent Biologics (8.33%) - Kelun-Biotech (8.15%) - Heng Rui Medicine (8.08%) - CanSino Biologics (8.07%) - New Horizon Health (6.13%) - Bai Li Tianheng (5.99%) - BeiGene (5.97%) - Hansoh Pharmaceutical (4.15%) - Rongchang Biologics (4.05%) - CanSino Biologics-B (3.91%) [1]. Fund Manager Background - Zheng Ning, the fund manager, has a master's degree and has previously held positions at Taikang Asset Management and Zhonggeng Fund Management. He joined Zhongyin Fund Management in 2022 and has been managing the Zhongyin Innovation Medical Mixed Fund since July 1, 2022 [2].

Core Viewpoint - The article highlights the significant policy support for the brain-computer interface (BCI) industry, with a focus on the implementation opinions released by multiple government departments aimed at fostering innovation and development in this sector by 2027 [1][2]. Summary by Sections Policy Implementation - On August 7, a joint implementation opinion was released by several government bodies, outlining 17 specific measures to promote the innovation and development of the BCI industry [2]. - The opinion sets a target for breakthroughs in key BCI technologies by 2027, establishing advanced technical, industrial, and standard systems [4]. Technological Development Goals - By 2027, the performance of electrodes, chips, and complete products is expected to reach international advanced levels, with applications in industrial manufacturing, healthcare, and consumer life accelerating [4]. - By 2030, the BCI industry is anticipated to significantly enhance its innovation capabilities, nurturing 2 to 3 globally influential leading enterprises and a number of specialized small and medium-sized enterprises [4]. Product Innovation - The implementation opinion emphasizes the need for high-performance products, including breakthroughs in implantable devices and the development of new product forms such as adhesive, ear, and clip-on devices [4][5]. - There is a focus on developing high-channel, high-speed brain signal acquisition chips and auxiliary devices that integrate multiple physiological signals to improve interaction control and perception assessment accuracy [5]. Industry Growth and Support - The opinion encourages the growth of leading enterprises in the BCI field and the formation of industry innovation consortia, supporting the cultivation of technology-driven small and medium enterprises [5]. - The BCI industry is expected to receive substantial support from the government, with new pricing mechanisms for medical devices related to BCI technology being established [7]. Market Potential - The global BCI market is projected to reach approximately $7 billion by 2030, with a compound annual growth rate (CAGR) of 16.4% from 2025 to 2030 [8]. - The domestic BCI market is expected to grow significantly, with a market size of 1.73 billion yuan in 2023, reflecting an increase of over 5% compared to 2020 [8]. - By 2040, the Chinese BCI market is forecasted to exceed 120 billion yuan, with an annual growth rate of 26% [8].

Group 1: Market Overview - 22 stocks had a closing order amount exceeding 1 billion yuan, with Tianyu Shuke leading at 2.95 billion yuan [2] - The top three stocks by closing order volume were Jihua Group, Tianyu Shuke, and Jishi Media, with volumes of 418,600 hands, 396,600 hands, and 323,700 hands respectively [2] - Stocks with consecutive limit-up days included *ST Dongjing and *ST Yushun with 5 consecutive days, while Beiwai Technology, Furi Electronics, and Guoji Precision achieved 4 consecutive days [2] Group 2: Company Performance - Tianyu Shuke is expected to achieve a net profit attributable to shareholders of 18 million to 26 million yuan in the first half of the year, marking a turnaround from losses [2] - The company reported growth in data traffic business and implemented cost-reduction measures positively impacting performance [2] - Ningbo Yunsheng anticipates a net profit of 90 million to 135 million yuan for the first half of 2025, representing a year-on-year growth of 133.55% to 250.33% [3] Group 3: Industry Insights - The rare earth permanent magnet sector saw stocks like Zhenghai Magnetic Materials and Ningbo Yunsheng hitting the limit-up [3] - The semiconductor sector had stocks such as Fumanwei and Dongxin Co. also reaching limit-up, with Fumanwei confirming normal shipments of 5G RF chips [4][5] - The brain-computer interface sector is indirectly engaged by companies like Jihua Group and Innovation Medical through partnerships, although they do not directly develop the technology [6] Group 4: Investment Trends - The top net buying stocks on the Dragon and Tiger list included Shuo Beid, Dongxin Peace, and Lide Man, with net buying amounts of 533 million yuan, 245 million yuan, and 214 million yuan respectively [7] - Institutional net buying was led by Dongfang Precision and Dawi Co., with amounts of 161 million yuan and 57.87 million yuan respectively [7]

Group 1 - The stock of Innovation Medical reached the daily limit, with a turnover rate of 30.10% and a transaction amount of 2.05 billion yuan, showing a fluctuation of 11.20% [2] - Institutional investors net sold 109 million yuan, while brokerage seats collectively net bought 136 million yuan [2] - The stock was listed on the Shenzhen Stock Exchange's daily limit deviation list due to a deviation of 10.05% [2] Group 2 - The top five brokerage seats accounted for a total transaction of 454 million yuan, with a buying amount of 241 million yuan and a selling amount of 213 million yuan, resulting in a net buying of 27.19 million yuan [2] - Among the brokerage seats, four institutional special seats were involved, with a total buying amount of 75.62 million yuan and a selling amount of 185 million yuan, leading to a net sell of 109 million yuan [2] - Over the past six months, the stock has appeared on the daily limit list seven times, with an average price drop of 0.68% the next day and an average increase of 0.65% over the following five days [2] Group 3 - The stock saw a net inflow of 226 million yuan from main funds today, with a significant single net inflow of 211 million yuan and a large single fund inflow of 15.46 million yuan [2] - In the past five days, the main funds have seen a net inflow of 398 million yuan [2]

资金面上看，今日脑机接口概念板块获主力资金净流入4.21亿元，其中，17股获主力资金净流入，6股 主力资金净流入超3000万元，净流入资金居首的是际华集团，今日主力资金净流入3.88亿元，净流入资 金居前的还有创新医疗、汉威科技、三博脑科等，主力资金分别净流入2.26亿元、5017.95万元、 4944.78万元。 截至8月7日收盘，脑机接口概念上涨2.69%，位居概念板块涨幅第2，板块内，27股上涨，际华集团、 创新医疗等涨停，倍益康、翔宇医疗、爱朋医疗等涨幅居前，分别上涨17.75%、11.74%、8.45%。跌幅 居前的有谱尼测试、普利特、均普智能等，分别下跌1.77%、1.75%、1.68%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 稀土永磁 | 3.24 | 减肥药 | -1.70 | | 脑机接口 | 2.69 | CRO概念 | -1.66 | | 高压氧舱 | 2.56 | 创新药 | -1.41 | | 太赫兹 | 1.65 | 仿制药一致性评价 | -1.34 | | 血氧仪 | ...

Group 1 - The high-pressure oxygen chamber concept increased by 2.56%, ranking third among concept sectors, with five stocks rising, including Innovation Medical which hit the daily limit, and others like BeiYikang, Jinling Pharmaceutical, and Yingkang Life showing gains of 17.75%, 3.79%, and 1.25% respectively [1][2] - The main funds net inflow into the high-pressure oxygen chamber concept was 239 million yuan, with Innovation Medical receiving the highest net inflow of 226 million yuan, followed by Jinling Pharmaceutical and Yingkang Life with net inflows of 41.83 million yuan and 6.52 million yuan respectively [2][3] - The net inflow ratios for Innovation Medical, Jinling Pharmaceutical, and Yingkang Life were 11.04%, 8.08%, and 4.30% respectively, indicating strong investor interest in these stocks [3] Group 2 - The top gainers in the high-pressure oxygen chamber concept included Innovation Medical, Jinling Pharmaceutical, and Yingkang Life, while the top losers were Weiao Co., Samsung Medical, and Tiejian Heavy Industry, with declines of 1.74%, 0.92%, and 0.69% respectively [1][4] - The trading volume and turnover rates for the leading stocks in the high-pressure oxygen chamber concept were significant, with Innovation Medical showing a turnover rate of 30.10% and a trading volume of 22.62 million yuan [3]

沪指8月7日上涨0.16%，申万所属行业中，今日上涨的有18个，涨幅居前的行业为有色金属、美容护 理，涨幅分别为1.20%、0.99%。跌幅居前的行业为医药生物、电力设备，跌幅分别为0.92%、0.74%。 医药生物行业位居今日跌幅榜首位。 | 代码 | 简称 | 今日涨跌幅（%） | 今日换手率（%） | 主力资金流量（万元） | | --- | --- | --- | --- | --- | | 688166 | 博瑞医药 | -5.70 | 3.89 | 23275.85 | | 002173 | 创新医疗 | 10.01 | 30.10 | 22618.18 | | 000710 | 贝瑞基因 | 5.26 | 23.64 | 20015.67 | | 300289 | 利德曼 | 20.02 | 21.71 | 17141.65 | | 002022 | 科华生物 | 9.96 | 12.63 | 15290.70 | | 300981 | 中红医疗 | 19.99 | 8.06 | 11833.89 | | 300760 | 迈瑞医疗 | 1.09 | 0.60 | 11395.45 | | 00 ...